10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

JBCHEPHARM (JB Chemicals & Pharmaceuticals Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze JB Chemicals & Pharmaceuticals Limited together

I guess you are interested in JB Chemicals & Pharmaceuticals Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – JB Chemicals & Pharmaceuticals Limited’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – JB Chemicals & Pharmaceuticals Limited’s Price Targets

I'm going to help you getting a better view of JB Chemicals & Pharmaceuticals Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about JB Chemicals & Pharmaceuticals Limited

I send you an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited.

1. Quick Overview

1.1. Quick analysis of JB Chemicals & Pharmaceuticals Limited (30 sec.)










1.2. What can you expect buying and holding a share of JB Chemicals & Pharmaceuticals Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.70
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR216.33
Expected worth in 1 year
INR344.33
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR187.74
Return On Investment
11.6%

For what price can you sell your share?

Current Price per Share
INR1,614.40
Expected price per share
INR1,396 - INR1,783
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of JB Chemicals & Pharmaceuticals Limited (5 min.)




Live pricePrice per Share (EOD)
INR1,614.40
Intrinsic Value Per Share
INR236.92 - INR1,237.38
Total Value Per Share
INR453.26 - INR1,453.71

2.2. Growth of JB Chemicals & Pharmaceuticals Limited (5 min.)




Is JB Chemicals & Pharmaceuticals Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$401.6m$342m$59.6m14.9%

How much money is JB Chemicals & Pharmaceuticals Limited making?

Current yearPrevious yearGrowGrow %
Making money$77.1m$64.6m$12.5m16.2%
Net Profit Margin16.8%16.0%--

How much money comes from the company's main activities?

2.3. Financial Health of JB Chemicals & Pharmaceuticals Limited (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of JB Chemicals & Pharmaceuticals Limited?

Welcome investor! JB Chemicals & Pharmaceuticals Limited's management wants to use your money to grow the business. In return you get a share of JB Chemicals & Pharmaceuticals Limited.

First you should know what it really means to hold a share of JB Chemicals & Pharmaceuticals Limited. And how you can make/lose money.

Speculation

The Price per Share of JB Chemicals & Pharmaceuticals Limited is INR1,614. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of JB Chemicals & Pharmaceuticals Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in JB Chemicals & Pharmaceuticals Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR216.33. Based on the TTM, the Book Value Change Per Share is INR32.00 per quarter. Based on the YOY, the Book Value Change Per Share is INR25.97 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR14.94 per quarter.
Based on historical numbers we can estimate the returns while holding a share of JB Chemicals & Pharmaceuticals Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.490.0%0.490.0%0.410.0%0.400.0%0.360.0%0.250.0%
Usd Book Value Change Per Share0.370.0%0.370.0%0.300.0%0.310.0%0.290.0%0.180.0%
Usd Dividend Per Share0.170.0%0.170.0%0.120.0%0.130.0%0.110.0%0.080.0%
Usd Total Gains Per Share0.550.0%0.550.0%0.420.0%0.440.0%0.400.0%0.260.0%
Usd Price Per Share18.90-18.90-19.31-20.37-18.85-11.50-
Price to Earnings Ratio38.86-38.86-47.35-53.69-53.71-41.55-
Price-to-Total Gains Ratio34.41-34.41-46.01-48.96-48.45-54.51-
Price to Book Ratio7.47-7.47-8.95-9.60-10.22-7.13-
Price-to-Total Gains Ratio34.41-34.41-46.01-48.96-48.45-54.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.88848
Number of shares52
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.170.11
Usd Book Value Change Per Share0.370.29
Usd Total Gains Per Share0.550.40
Gains per Quarter (52 shares)28.5520.91
Gains per Year (52 shares)114.2283.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13678104226174
27315621845123158
310923433267184242
414531144689245326
5182389560112307410
6218467674134368494
7254545788156429578
8291623902179490662
93277011016201552746
103637791130223613830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%18.02.00.090.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.01.00.095.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of JB Chemicals & Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--31.99831.9980%25.966+23%26.432+21%25.192+27%15.258+110%
Book Value Per Share--216.333216.3330%184.335+17%186.346+16%162.456+33%124.794+73%
Current Ratio--3.0413.0410%2.135+42%2.644+15%3.150-3%3.191-5%
Debt To Asset Ratio--0.1970.1970%0.268-27%0.256-23%0.227-13%0.218-10%
Debt To Equity Ratio--0.2450.2450%0.366-33%0.348-30%0.300-18%0.284-14%
Dividend Per Share--14.93614.9360%9.899+51%10.994+36%9.170+63%6.909+116%
Enterprise Value--252369575000.000252369575000.0000%255557692250.000-1%268976091036.720-6%249428725150.032+1%152383001103.992+66%
Eps--41.56041.5600%34.847+19%34.192+22%31.194+33%21.654+92%
Ev To Ebitda Ratio--24.45824.4580%27.377-11%31.428-22%33.072-26%25.329-3%
Ev To Sales Ratio--6.4416.4410%7.412-13%7.783-17%8.644-25%6.213+4%
Free Cash Flow Per Share--50.71450.7140%34.003+49%25.273+101%11.708+333%8.507+496%
Free Cash Flow To Equity Per Share--14.18914.1890%10.415+36%12.824+11%1.345+955%-1.913+113%
Gross Profit Margin--1.0001.0000%0.309+224%0.623+61%0.561+78%0.387+159%
Intrinsic Value_10Y_max--1237.381----------
Intrinsic Value_10Y_min--236.923----------
Intrinsic Value_1Y_max--46.662----------
Intrinsic Value_1Y_min--12.474----------
Intrinsic Value_3Y_max--199.136----------
Intrinsic Value_3Y_min--47.461----------
Intrinsic Value_5Y_max--422.665----------
Intrinsic Value_5Y_min--93.118----------
Market Cap251941662515.200-2%256308575000.000256308575000.0000%261669317250.000-2%274928499370.053-7%253286498150.032+1%154474808303.992+66%
Net Profit Margin--0.1680.1680%0.160+5%0.153+10%0.168+0%0.150+13%
Operating Margin--0.2200.2200%0.231-5%0.213+3%0.230-4%0.204+8%
Operating Ratio--0.5120.5120%1.048-51%0.709-28%0.737-31%0.796-36%
Pb Ratio7.4630%7.4657.4650%8.951-17%9.595-22%10.217-27%7.135+5%
Pe Ratio38.8450%38.85938.8590%47.350-18%53.691-28%53.709-28%41.552-6%
Price Per Share1614.4000%1615.0001615.0000%1650.000-2%1741.320-7%1610.792+0%982.738+64%
Price To Free Cash Flow Ratio31.8330%31.84531.8450%48.525-34%-46.605+246%-22.366+170%8.092+294%
Price To Total Gains Ratio34.3970%34.41034.4100%46.006-25%48.957-30%48.455-29%54.511-37%
Quick Ratio--2.4972.4970%1.768+41%2.075+20%2.612-4%2.908-14%
Return On Assets--0.1540.1540%0.138+12%0.136+13%0.151+2%0.131+18%
Return On Equity--0.1920.1920%0.189+2%0.182+5%0.195-1%0.167+15%
Total Gains Per Share--46.93446.9340%35.865+31%37.425+25%34.361+37%22.167+112%
Usd Book Value--401698440.000401698440.0000%342029528.100+17%344642972.700+17%299263585.140+34%229500933.480+75%
Usd Book Value Change Per Share--0.3740.3740%0.304+23%0.309+21%0.295+27%0.179+110%
Usd Book Value Per Share--2.5312.5310%2.157+17%2.180+16%1.901+33%1.460+73%
Usd Dividend Per Share--0.1750.1750%0.116+51%0.129+36%0.107+63%0.081+116%
Usd Enterprise Value--2952724027.5002952724027.5000%2990024999.325-1%3147020265.130-6%2918316084.255+1%1782881112.917+66%
Usd Eps--0.4860.4860%0.408+19%0.400+22%0.365+33%0.253+92%
Usd Free Cash Flow--94168620.00094168620.0000%63091629.900+49%46985823.300+100%21881852.460+330%15829880.040+495%
Usd Free Cash Flow Per Share--0.5930.5930%0.398+49%0.296+101%0.137+333%0.100+496%
Usd Free Cash Flow To Equity Per Share--0.1660.1660%0.122+36%0.150+11%0.016+955%-0.022+113%
Usd Market Cap2947717451.428-2%2998810327.5002998810327.5000%3061531011.825-2%3216663442.630-7%2963452028.355+1%1807355257.157+66%
Usd Price Per Share18.8880%18.89618.8960%19.305-2%20.373-7%18.846+0%11.498+64%
Usd Profit--77170860.00077170860.0000%64657452.600+19%63259688.700+22%57455585.460+34%39840419.970+94%
Usd Revenue--458404830.000458404830.0000%403377507.000+14%410082699.000+12%349713751.140+31%259291546.020+77%
Usd Total Gains Per Share--0.5490.5490%0.420+31%0.438+25%0.402+37%0.259+112%
 EOD+4 -4MRQTTM+0 -0YOY+31 -93Y+31 -95Y+31 -910Y+33 -7

3.3 Fundamental Score

Let's check the fundamental score of JB Chemicals & Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1538.845
Price to Book Ratio (EOD)Between0-17.463
Net Profit Margin (MRQ)Greater than00.168
Operating Margin (MRQ)Greater than00.220
Quick Ratio (MRQ)Greater than12.497
Current Ratio (MRQ)Greater than13.041
Debt to Asset Ratio (MRQ)Less than10.197
Debt to Equity Ratio (MRQ)Less than10.245
Return on Equity (MRQ)Greater than0.150.192
Return on Assets (MRQ)Greater than0.050.154
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of JB Chemicals & Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.341
Ma 20Greater thanMa 501,700.745
Ma 50Greater thanMa 1001,668.788
Ma 100Greater thanMa 2001,635.631
OpenGreater thanClose1,632.600
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About JB Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2025-06-21 22:36:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ JB Chemicals & Pharmaceuticals Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compareΒ JB Chemicals & Pharmaceuticals Limited to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 16.8%Β means thatΒ ₹0.17 for each ₹1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 16.8%. The company is making a huge profit. +2
  • The TTM is 16.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.8%TTM16.8%0.0%
TTM16.8%YOY16.0%+0.8%
TTM16.8%5Y16.8%+0.0%
5Y16.8%10Y15.0%+1.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ JB Chemicals & Pharmaceuticals Limited is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ JB Chemicals & Pharmaceuticals Limited to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • 15.4% Return on Assets means thatΒ JB Chemicals & Pharmaceuticals Limited generatedΒ ₹0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 15.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 15.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.4%TTM15.4%0.0%
TTM15.4%YOY13.8%+1.6%
TTM15.4%5Y15.1%+0.3%
5Y15.1%10Y13.1%+2.1%
4.3.1.3. Return on Equity

Shows how efficient JB Chemicals & Pharmaceuticals Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ JB Chemicals & Pharmaceuticals Limited to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • 19.2% Return on Equity means JB Chemicals & Pharmaceuticals Limited generated ₹0.19Β for eachΒ ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 19.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 19.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.2%TTM19.2%0.0%
TTM19.2%YOY18.9%+0.3%
TTM19.2%5Y19.5%-0.3%
5Y19.5%10Y16.7%+2.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of JB Chemicals & Pharmaceuticals Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient JB Chemicals & Pharmaceuticals Limited is operatingΒ .

  • Measures how much profit JB Chemicals & Pharmaceuticals Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ JB Chemicals & Pharmaceuticals Limited to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 22.0%Β means the company generated ₹0.22 Β for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 22.0%. The company is operating efficient. +1
  • The TTM is 22.0%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ22.0%TTM22.0%0.0%
TTM22.0%YOY23.1%-1.1%
TTM22.0%5Y23.0%-1.0%
5Y23.0%10Y20.4%+2.6%
4.3.2.2. Operating Ratio

Measures how efficient JB Chemicals & Pharmaceuticals Limited is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.51 means that the operating costs are ₹0.51 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.512. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.512. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.512TTM0.5120.000
TTM0.512YOY1.048-0.537
TTM0.5125Y0.737-0.226
5Y0.73710Y0.796-0.059
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of JB Chemicals & Pharmaceuticals Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if JB Chemicals & Pharmaceuticals Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.04Β means the company has ₹3.04 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 3.041. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.041. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.041TTM3.0410.000
TTM3.041YOY2.135+0.906
TTM3.0415Y3.150-0.109
5Y3.15010Y3.191-0.041
4.4.3.2. Quick Ratio

Measures if JB Chemicals & Pharmaceuticals Limited is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ JB Chemicals & Pharmaceuticals Limited to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.50Β means the company can pay off ₹2.50 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 2.497. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.497. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.497TTM2.4970.000
TTM2.497YOY1.768+0.729
TTM2.4975Y2.612-0.115
5Y2.61210Y2.908-0.296
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of JB Chemicals & Pharmaceuticals Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of JB Chemicals & Pharmaceuticals LimitedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ JB Chemicals & Pharmaceuticals Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.20Β means that JB Chemicals & Pharmaceuticals Limited assets areΒ financed with 19.7% credit (debt) and the remaining percentage (100% - 19.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.197. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.197. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.197TTM0.1970.000
TTM0.197YOY0.268-0.071
TTM0.1975Y0.227-0.031
5Y0.22710Y0.218+0.009
4.5.4.2. Debt to Equity Ratio

Measures ifΒ JB Chemicals & Pharmaceuticals Limited is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ JB Chemicals & Pharmaceuticals Limited to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 24.5% means that company has ₹0.24 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The MRQ is 0.245. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.245. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.245TTM0.2450.000
TTM0.245YOY0.366-0.121
TTM0.2455Y0.300-0.055
5Y0.30010Y0.284+0.016
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every ₹1 in earnings JB Chemicals & Pharmaceuticals Limited generates.

  • Above 15 is considered overpriced butΒ always compareΒ JB Chemicals & Pharmaceuticals Limited to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 38.86 means the investor is paying ₹38.86Β for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 38.845. Based on the earnings, the company is overpriced. -1
  • The MRQ is 38.859. Based on the earnings, the company is overpriced. -1
  • The TTM is 38.859. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD38.845MRQ38.859-0.014
MRQ38.859TTM38.8590.000
TTM38.859YOY47.350-8.491
TTM38.8595Y53.709-14.850
5Y53.70910Y41.552+12.157
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 31.833. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 31.845. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 31.845. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD31.833MRQ31.845-0.012
MRQ31.845TTM31.8450.000
TTM31.845YOY48.525-16.680
TTM31.8455Y-22.366+54.211
5Y-22.36610Y8.092-30.458
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ JB Chemicals & Pharmaceuticals Limited is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 7.47 means the investor is paying ₹7.47Β for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of JB Chemicals & Pharmaceuticals Limited:

  • The EOD is 7.463. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.465. Based on the equity, the company is overpriced. -1
  • The TTM is 7.465. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.463MRQ7.465-0.003
MRQ7.465TTM7.4650.000
TTM7.465YOY8.951-1.486
TTM7.4655Y10.217-2.752
5Y10.21710Y7.135+3.082
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets42,737,800
Total Liabilities8,404,600
Total Stockholder Equity34,333,200
 As reported
Total Liabilities 8,404,600
Total Stockholder Equity+ 34,333,200
Total Assets = 42,737,800

Assets

Total Assets42,737,800
Total Current Assets19,227,400
Long-term Assets23,510,400
Total Current Assets
Cash And Cash Equivalents 1,294,500
Short-term Investments 3,171,100
Net Receivables 8,153,800
Inventory 5,289,500
Other Current Assets 1,318,500
Total Current Assets  (as reported)19,227,400
Total Current Assets  (calculated)19,227,400
+/-0
Long-term Assets
Property Plant Equipment 6,566,400
Goodwill 574,600
Intangible Assets 13,171,400
Long-term Assets Other 2,918,200
Long-term Assets  (as reported)23,510,400
Long-term Assets  (calculated)23,230,600
+/- 279,800

Liabilities & Shareholders' Equity

Total Current Liabilities6,323,300
Long-term Liabilities2,081,300
Total Stockholder Equity34,333,200
Total Current Liabilities
Short-term Debt 215,300
Short Long Term Debt 138,000
Accounts payable 4,107,200
Other Current Liabilities 2,000,800
Total Current Liabilities  (as reported)6,323,300
Total Current Liabilities  (calculated)6,461,300
+/- 138,000
Long-term Liabilities
Capital Lease Obligations 140,900
Long-term Liabilities Other 19,000
Long-term Liabilities  (as reported)2,081,300
Long-term Liabilities  (calculated)159,900
+/- 1,921,400
Total Stockholder Equity
Common Stock155,700
Accumulated Other Comprehensive Income 34,177,500
Total Stockholder Equity (as reported)34,333,200
Total Stockholder Equity (calculated)34,333,200
+/-0
Other
Capital Stock155,700
Cash and Short Term Investments 4,465,600
Common Stock Shares Outstanding 158,705
Liabilities and Stockholders Equity 42,737,800
Net Debt -1,015,600
Net Invested Capital 34,471,200
Net Working Capital 12,904,100
Property Plant and Equipment Gross 6,566,400
Short Long Term Debt Total 278,900



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-31
> Total Assets 
5,052,762
7,122,927
7,413,071
7,463,139
8,369,680
9,993,796
11,977,989
13,002,000
13,510,132
14,872,470
15,573,841
16,740,386
17,648,899
17,910,005
18,135,611
22,381,152
26,074,022
35,538,700
39,941,271
42,737,800
42,737,80039,941,27135,538,70026,074,02222,381,15218,135,61117,910,00517,648,89916,740,38615,573,84114,872,47013,510,13213,002,00011,977,9899,993,7968,369,6807,463,1397,413,0717,122,9275,052,762
   > Total Current Assets 
3,550,632
4,545,832
4,722,061
4,854,194
5,658,391
6,522,531
8,662,190
9,437,068
9,806,452
10,830,163
7,777,559
7,948,902
10,469,978
10,495,753
10,727,284
15,526,024
12,748,550
15,280,300
18,533,453
19,227,400
19,227,40018,533,45315,280,30012,748,55015,526,02410,727,28410,495,75310,469,9787,948,9027,777,55910,830,1639,806,4529,437,0688,662,1906,522,5315,658,3914,854,1944,722,0614,545,8323,550,632
       Cash And Cash Equivalents 
116,003
203,857
149,609
438,454
778,619
1,268,857
2,195,325
137,242
85,557
164,081
119,999
87,447
279,428
353,968
290,079
286,855
565,441
769,300
882,151
1,294,500
1,294,500882,151769,300565,441286,855290,079353,968279,42887,447119,999164,08185,557137,2422,195,3251,268,857778,619438,454149,609203,857116,003
       Short-term Investments 
265,036
373,136
601,316
579,992
596,819
681,148
2,989,218
3,979,792
4,972,588
5,559,545
1,952,490
2,249,616
3,837,660
3,606,499
3,338,126
6,649,748
1,062
2,159,300
3,714,202
3,171,100
3,171,1003,714,2022,159,3001,0626,649,7483,338,1263,606,4993,837,6602,249,6161,952,4905,559,5454,972,5883,979,7922,989,218681,148596,819579,992601,316373,136265,036
       Net Receivables 
2,727,102
3,410,720
3,639,772
3,028,007
4,004,624
4,051,972
1,432,858
1,976,796
32,485
2,631,176
2,757,323
2,749,861
3,073,200
3,288,723
3,613,525
3,890,191
6,238,844
5,771,700
7,042,815
8,153,800
8,153,8007,042,8155,771,7006,238,8443,890,1913,613,5253,288,7233,073,2002,749,8612,757,3232,631,17632,4851,976,7961,432,8584,051,9724,004,6243,028,0073,639,7723,410,7202,727,102
       Inventory 
643,061
835,724
746,914
807,740
834,715
1,116,701
1,010,324
1,045,349
1,344,002
1,502,733
1,879,833
2,001,686
2,137,314
2,437,576
2,746,697
3,474,468
4,099,611
4,304,900
5,025,128
5,289,500
5,289,5005,025,1284,304,9004,099,6113,474,4682,746,6972,437,5762,137,3142,001,6861,879,8331,502,7331,344,0021,045,3491,010,3241,116,701834,715807,740746,914835,724643,061
   > Long-term Assets 
1,502,130
2,577,095
2,691,010
2,608,945
2,711,289
3,471,265
3,315,799
3,564,932
3,703,680
4,042,307
7,796,275
8,791,484
7,178,921
7,414,252
7,408,327
6,855,128
13,325,472
20,258,400
21,407,818
23,510,400
23,510,40021,407,81820,258,40013,325,4726,855,1287,408,3277,414,2527,178,9218,791,4847,796,2754,042,3073,703,6803,564,9323,315,7993,471,2652,711,2892,608,9452,691,0102,577,0951,502,130
       Property Plant Equipment 
1,473,033
2,333,078
2,443,042
2,327,138
2,263,795
2,446,563
2,791,903
3,001,133
3,316,237
3,590,570
5,018,973
6,010,328
5,811,134
5,595,066
5,841,966
5,696,550
5,668,159
5,764,200
6,348,823
6,566,400
6,566,4006,348,8235,764,2005,668,1595,696,5505,841,9665,595,0665,811,1346,010,3285,018,9733,590,5703,316,2373,001,1332,791,9032,446,5632,263,7952,327,1382,443,0422,333,0781,473,033
       Goodwill 
0
169,023
169,023
169,023
169,023
169,023
0
169,023
169,023
169,023
531,400
531,400
531,400
531,400
531,400
574,592
574,592
574,600
574,592
574,600
574,600574,592574,600574,592574,592531,400531,400531,400531,400531,400169,023169,023169,0230169,023169,023169,023169,023169,0230
       Long Term Investments 
0
0
0
0
0
0
0
0
27,480
1,848,283
2,333,940
1,859,738
499,579
958,756
0
0
0
0
0
0
000000958,756499,5791,859,7382,333,9401,848,28327,48000000000
       Intangible Assets 
0
70
3,715
37,099
34,940
4,689
360,426
221,062
83,824
77,750
162,320
290,340
226,523
233,775
300,924
321,052
6,713,944
13,222,800
13,884,546
13,171,400
13,171,40013,884,54613,222,8006,713,944321,052300,924233,775226,523290,340162,32077,75083,824221,062360,4264,68934,94037,0993,715700
       Other Assets 
0
0
0
0
0
0
0
0
107,116
177,485
7
99,678
110,285
88,967
105,270
133,847
241,556
123,835
0
0
00123,835241,556133,847105,27088,967110,28599,6787177,485107,11600000000
> Total Liabilities 
1,748,994
2,938,307
2,882,825
2,774,224
2,688,505
3,078,371
2,278,460
2,799,288
3,082,008
4,923,728
4,620,571
3,081,891
3,205,601
3,080,748
3,755,708
4,246,853
4,687,893
10,735,200
10,707,978
8,404,600
8,404,60010,707,97810,735,2004,687,8934,246,8533,755,7083,080,7483,205,6013,081,8914,620,5714,923,7283,082,0082,799,2882,278,4603,078,3712,688,5052,774,2242,882,8252,938,3071,748,994
   > Total Current Liabilities 
638,656
1,009,739
764,521
858,075
1,162,401
1,225,087
1,883,222
2,389,732
2,762,704
4,597,491
4,357,995
2,812,084
2,749,006
2,432,357
3,128,460
3,452,737
3,837,156
5,544,500
8,682,261
6,323,300
6,323,3008,682,2615,544,5003,837,1563,452,7373,128,4602,432,3572,749,0062,812,0844,357,9954,597,4912,762,7042,389,7321,883,2221,225,0871,162,401858,075764,5211,009,739638,656
       Short-term Debt 
0
0
0
0
0
0
559,868
439,436
927,148
1,276,921
1,930,207
488,603
292,928
257,977
344,466
398,465
339,412
1,739,100
3,443,789
215,300
215,3003,443,7891,739,100339,412398,465344,466257,977292,928488,6031,930,2071,276,921927,148439,436559,868000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
932,032
883
4,000
488,603
292,928
257,977
320,361
326,446
263,150
1,650,200
3,335,000
138,000
138,0003,335,0001,650,200263,150326,446320,361257,977292,928488,6034,000883932,03200000000
       Accounts payable 
258,744
634,848
441,476
386,560
455,032
502,114
370,902
605,076
607,478
775,139
908,509
989,771
1,103,950
1,173,746
1,679,656
1,869,234
2,244,797
2,386,400
3,563,103
4,107,200
4,107,2003,563,1032,386,4002,244,7971,869,2341,679,6561,173,7461,103,950989,771908,509775,139607,478605,076370,902502,114455,032386,560441,476634,848258,744
       Other Current Liabilities 
1,182,672
374,891
323,045
471,515
1,626,127
1,943,556
952,452
1,345,220
1,228,078
2,542,999
-2,145,687
1,287,697
1,276,275
843,207
911,336
1,079,935
1,148,850
236,500
1,427,913
2,000,800
2,000,8001,427,913236,5001,148,8501,079,935911,336843,2071,276,2751,287,697-2,145,6872,542,9991,228,0781,345,220952,4521,943,5561,626,127471,515323,045374,8911,182,672
   > Long-term Liabilities 
1,110,338
1,928,568
2,118,304
1,916,149
1,526,104
1,853,284
395,238
409,556
319,304
326,237
262,576
269,807
456,595
648,391
627,248
794,116
850,737
5,190,700
2,025,717
2,081,300
2,081,3002,025,7175,190,700850,737794,116627,248648,391456,595269,807262,576326,237319,304409,556395,2381,853,2841,526,1041,916,1492,118,3041,928,5681,110,338
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,292
51,414
206,176
3,985,413
0
0
003,985,413206,17651,41412,29200000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
314,420
322,236
310,152
269,807
456,595
648,391
680,735
742,702
644,561
0
0
0
000644,561742,702680,735648,391456,595269,807310,152322,236314,42000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,576
0
0
0
0
0
0
0000001,5760000000000000
> Total Stockholder Equity
3,303,768
4,184,620
4,530,246
4,688,915
5,681,175
6,915,425
9,699,529
10,202,712
10,428,124
9,948,742
10,937,310
13,636,690
14,415,580
14,801,224
14,354,893
18,097,248
21,341,230
24,803,500
29,233,300
34,333,200
34,333,20029,233,30024,803,50021,341,23018,097,24814,354,89314,801,22414,415,58013,636,69010,937,3109,948,74210,428,12410,202,7129,699,5296,915,4255,681,1754,688,9154,530,2464,184,6203,303,768
   Common Stock
160,736
168,653
168,653
168,653
168,653
169,034
169,415
169,415
169,463
169,616
169,640
169,640
167,140
160,473
154,564
154,564
154,564
154,800
155,195
155,700
155,700155,195154,800154,564154,564154,564160,473167,140169,640169,640169,616169,463169,415169,415169,034168,653168,653168,653168,653160,736
   Retained Earnings 
3,143,032
4,015,865
4,361,593
4,520,262
5,512,522
6,746,391
4,134,110
4,543,494
4,792,480
4,312,287
5,405,686
8,066,148
9,291,153
11,024,320
12,329,467
15,847,935
18,427,069
22,757,071
25,132,989
0
025,132,98922,757,07118,427,06915,847,93512,329,46711,024,3209,291,1538,066,1485,405,6864,312,2874,792,4804,543,4944,134,1106,746,3915,512,5224,520,2624,361,5934,015,8653,143,032
   Accumulated Other Comprehensive Income 
-722,943
-839,421
-1,006,250
-1,198,568
-1,398,924
-1,581,313
-1,761,508
-1,984,851
-2,244,564
-2,664,627
-3,058,092
-3,503,110
-4,045,777
-4,534,457
-5,154,102
1,583,581
2,248,429
2,698,761
1,267,816
34,177,500
34,177,5001,267,8162,698,7612,248,4291,583,581-5,154,102-4,534,457-4,045,777-3,503,110-3,058,092-2,664,627-2,244,564-1,984,851-1,761,508-1,581,313-1,398,924-1,198,568-1,006,250-839,421-722,943
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
507,682
507,682
507,682
507,682
507,682
507,682
507,682
697,292
0
0
00697,292507,682507,682507,682507,682507,682507,682507,6820000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
722,943
839,523
1,006,250
1,198,568
1,398,924
4,562,211
5,396,004
5,489,803
5,466,181
5,466,839
5,361,984
5,400,902
4,957,287
3,616,431
507,682
2,094,749
2,759,597
-807,132
2,677,300
0
02,677,300-807,1322,759,5972,094,749507,6823,616,4314,957,2875,400,9025,361,9845,466,8395,466,1815,489,8035,396,0044,562,2111,398,9241,198,5681,006,250839,523722,943



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue39,179,900
Cost of Revenue-13,165,500
Gross Profit26,014,40026,014,400
 
Operating Income (+$)
Gross Profit26,014,400
Operating Expense-6,876,100
Operating Income19,138,30019,138,300
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense6,876,1000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-117,300
Other Finance Cost-0
Net Interest Income-117,300
 
Pretax Income (+$)
Operating Income19,138,300
Net Interest Income-117,300
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,873,90029,402,700
EBIT - interestExpense = 8,490,700
8,873,900
6,713,100
Interest Expense117,300
Earnings Before Interest and Taxes (EBIT)8,608,0008,991,200
Earnings Before Interest and Taxes (EBITDA)10,318,400
 
After tax Income (+$)
Income Before Tax8,873,900
Tax Provision-2,278,100
Net Income From Continuing Ops6,595,8006,595,800
Net Income6,595,800
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses20,041,600
Total Other Income/Expenses Net-10,264,400117,300
 

Technical Analysis of JB Chemicals & Pharmaceuticals Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of JB Chemicals & Pharmaceuticals Limited. The general trend of JB Chemicals & Pharmaceuticals Limited is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine JB Chemicals & Pharmaceuticals Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. JB Chemicals & Pharmaceuticals Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of JB Chemicals & Pharmaceuticals Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,663 < 1,663 < 1,783.

The bearish price targets are: 1,507 > 1,495 > 1,396.

Know someone who trades $JBCHEPHARM? Share this with them.πŸ‘‡

JB Chemicals & Pharmaceuticals Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of JB Chemicals & Pharmaceuticals Limited. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

JB Chemicals & Pharmaceuticals Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of JB Chemicals & Pharmaceuticals Limited. The current macd is -18.34510654.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the JB Chemicals & Pharmaceuticals Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for JB Chemicals & Pharmaceuticals Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the JB Chemicals & Pharmaceuticals Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
JB Chemicals & Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) ChartJB Chemicals & Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of JB Chemicals & Pharmaceuticals Limited. The current adx is 21.88.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell JB Chemicals & Pharmaceuticals Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
JB Chemicals & Pharmaceuticals Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of JB Chemicals & Pharmaceuticals Limited. The current sar is 1,757.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
JB Chemicals & Pharmaceuticals Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of JB Chemicals & Pharmaceuticals Limited. The current rsi is 38.34. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
JB Chemicals & Pharmaceuticals Limited Daily Relative Strength Index (RSI) ChartJB Chemicals & Pharmaceuticals Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of JB Chemicals & Pharmaceuticals Limited. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the JB Chemicals & Pharmaceuticals Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
JB Chemicals & Pharmaceuticals Limited Daily Stochastic Oscillator ChartJB Chemicals & Pharmaceuticals Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of JB Chemicals & Pharmaceuticals Limited. The current cci is -94.97267441.

JB Chemicals & Pharmaceuticals Limited Daily Commodity Channel Index (CCI) ChartJB Chemicals & Pharmaceuticals Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of JB Chemicals & Pharmaceuticals Limited. The current cmo is -36.05135633.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
JB Chemicals & Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) ChartJB Chemicals & Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of JB Chemicals & Pharmaceuticals Limited. The current willr is -98.53258524.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
JB Chemicals & Pharmaceuticals Limited Daily Williams %R ChartJB Chemicals & Pharmaceuticals Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of JB Chemicals & Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of JB Chemicals & Pharmaceuticals Limited. The current atr is 43.43.

JB Chemicals & Pharmaceuticals Limited Daily Average True Range (ATR) ChartJB Chemicals & Pharmaceuticals Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of JB Chemicals & Pharmaceuticals Limited. The current obv is 5,552,337.

JB Chemicals & Pharmaceuticals Limited Daily On-Balance Volume (OBV) ChartJB Chemicals & Pharmaceuticals Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of JB Chemicals & Pharmaceuticals Limited. The current mfi is 34.34.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
JB Chemicals & Pharmaceuticals Limited Daily Money Flow Index (MFI) ChartJB Chemicals & Pharmaceuticals Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for JB Chemicals & Pharmaceuticals Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

JB Chemicals & Pharmaceuticals Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of JB Chemicals & Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.341
Ma 20Greater thanMa 501,700.745
Ma 50Greater thanMa 1001,668.788
Ma 100Greater thanMa 2001,635.631
OpenGreater thanClose1,632.600
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of JB Chemicals & Pharmaceuticals Limited with someone you think should read this too:
  • Are you bullish or bearish on JB Chemicals & Pharmaceuticals Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about JB Chemicals & Pharmaceuticals Limited

I send you an email if I find something interesting about JB Chemicals & Pharmaceuticals Limited.


Comments

How you think about this?

Leave a comment

Stay informed about JB Chemicals & Pharmaceuticals Limited.

Receive notifications about JB Chemicals & Pharmaceuticals Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.